Jiangsu (SH:688426) Xin Lang Cai Jing·2025-09-23 01:50Core Points - The stock price of Kangwei Century has decreased by 2.05% on September 23, trading at 26.32 CNY per share with a market capitalization of 2.961 billion CNY [1] - Year-to-date, the stock has dropped by 8.00%, with a recent decline of 10.05% over the last five trading days [1] - The company has shown a revenue growth of 29.74% year-on-year for the first half of 2025, but reported a net loss of 55.911 million CNY, a decrease of 11.70% compared to the previous year [2] Company Overview - Jiangsu Kangwei Century Biotechnology Co., Ltd. was established on September 3, 2010, and went public on October 25, 2022 [1] - The company specializes in the research, production, and sales of molecular detection products, with 89.14% of its revenue coming from product sales and 10.86% from services [1] - As of June 30, 2025, the number of shareholders increased by 0.25% to 3,949, while the average number of circulating shares per person decreased by 0.25% to 9,621 shares [2] Shareholder Information - The largest circulating shareholder is Rongtong Health Industry Flexible Allocation Mixed A/B, holding 3.6 million shares, a decrease of 161,200 shares from the previous period [2] - New shareholder, China Europe Times Pioneer Stock A, holds 2 million shares, ranking as the third-largest circulating shareholder [2] - Other notable changes include an increase in holdings by Yuanxin Yongfeng Medical Health A and Yuanxin Yongfeng Ju You A, while Rongtong Xin New Growth Mixed A saw a decrease in holdings [2]